INTRODUCTION
The gastrointestinal (GI) tract is the largest endocrine organ in the human body, producing a wide variety of biologically active products. Many of the enteric endocrine cells reside within the epithelial cells of intestinal mucosa where stimuli from the lumen or surrounding cells can influence their cellular biology. 1 The best-characterized subset of enteric endocrine cells are enterochromaffin (EC) cells, which synthesize and release serotonin (5-hydroxytryptamine (5-HT)) and are the main source of 5-HT in the GI tract. 2,3 5-HT is an important enteric mucosal signaling molecule that can influence the maintenance of intestinal homeostasis, specifically motor and secretory functions. 4 -6 The release of 5-HT increases motility of the gut and is also an extremely important mediator of nausea and satiety. 7, 8 Abnormal regulation of 5-HT in the human gut has been implicated with a diverse array of GI disorders such as inflammatory bowel disease, 9,10 irritable bowel syndrome (IBS), 9, 11, 12 celiac disease, 13 colorectal cancer, 14,15 diverticular disease, 16 and enteric bacterial, viral, and parasitic infection. 17 -22 Recently, we have demonstrated a critical role of 5-HT in the activation of immune response and generation of mucosal inflammation in experimental model of colitis. 23, 24 Although 5-HT and EC cell biology have been implicated in a plethora of GI disorders, the precise mechanism regulating the observed changes in 5-HT content and EC cell numbers during GI disorder remains unclear.
Considering the location of EC cells in the epithelial layer of the gut mucosa, it is very likely that immune cells play an important role in EC cell biology in the context of various GI disorders. In patients with postinfectious IBS, observation of immune activation (increased number of CD3 + T cells) has been associated with increased EC cell numbers, which is suggestive of a link between these two systems. 25, 26 This association between the immune system and endocrine system of the GI tract also holds true in animal models of postinfectious IBS. 20, 27 The notion of an immune -endocrine axis in the GI tract is further supported by the findings that EC cells in mucosa of the ileum and colon of rhesus monkeys are in direct or close contact with lymphocytes. 28 Two recent studies from our laboratory have uncovered a pivotal role for the immune system in EC cell biology. 21, 22 Using the nematode Trichuris muris model of intestinal infection, we have observed upregulation in the IL-13-mediated immunological control of enterochromaffin cell hyperplasia and serotonin production in the gut 
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number of EC cells and 5-HT amount following infection. 21 This infection-induced increase in EC cells or in 5-HT was not evident in severe combined immunodeficient (SCID) mice. EC cell numbers and 5-HT amount significantly increased following reconstitution of SCID mice with CD4 + T cells from infected mice and this was accompanied by an upregulation of colonic CD3 + T cells and T helper type 2 ( Th2) cytokines. In addition, laser capture microdissection-based molecular and immunofluorescence techniques revealed the presence of the interleukin-13 receptor 1 (IL-13R 1) on EC cell. 21 These findings demonstrate an important role for CD4 + T cells in EC cell function in enteric infection-induced gut inflammation. Recently, we have also demonstrated a difference in EC cell and 5-HT responses in Th1 and Th2 environments. 22 Higher amount of 5-HT and EC cell numbers were observed in mice that are resistant to infection and expel worms by generating a Th2-type immune response as compared with susceptible mice that developed chronic infection with the generation of a Th1 response. Utilizing Stat4-and Stat6-deficient mice, which are impaired in Th1 and Th2 response respectively, we have also shown impairment in the development of infection-induced EC cell hyperplasia and in 5-HT production in Stat6-deficient mice after T. muris infection. 22 These findings suggest the importance of the immunological profile of the inflammatory response in the regulation of EC cell biology in gut mucosa.
The involvement of immune response in the regulation of EC cell hyperplasia and 5-HT production in T. muris infection as well as the presence of IL-13R 1 in colonic 5-HT-expressing EC cells exemplifies the role of IL-13 in EC cell biology. In this study we solidify the role of IL-13 in EC cell biology utilizing IL-13-deficient (IL-13 − / − ) mice in T. muris infection model and a cell culture model for EC cells (BON cells). Our results demonstrate compelling evidence in favor of a role of IL-13 in EC cell biology at the molecular level in both an in vivo mouse model and in culture human model of EC cells.
RESULTS

IL-13 deficiency inhibits worm expulsion and development of infection-induced EC cell hyperplasia and 5-HT production in T. muris infection
BALB / c (wild-type) mice are resistant to T. muris infection and can expel almost all the worms within 21 days after infection, whereas IL-13 − / − mice on BALB / c background failed to clear the parasitic infection ( Figure 1a ). The clearance of parasite from wild-type mice was associated with significantly higher levels of IL-13 ( Figure 1b ) and IL-4 ( Figure 1c ) in the colon, which is in agreement with previous observations of T. muris -infected BALB / c mice. 21 IL-13 levels were elevated on both days 14 and 21 after infection in wild-type mice and, as expected, were not detectable in IL-13 − / − mice. IL-4 levels were increased in the colonic tissues of both the wild-type and IL-13 − / − mice in comparison with their noninfected controls. Notably, IL-4 levels were significantly higher in the IL-13 − / − mice compared with their wild-type counterparts on days 14 and day 21 after infection.
Significantly lower number of EC cells and 5-HT amount was detected in the colon of IL-13 − / − mice in comparison with wild-type mice after infection. We found that noninfected wild-type controls had significantly higher number of 5-HTexpressing EC cells compared with IL-13 − / − controls and, following infection, a progressive increase in 5-HT-expressing EC cells was observed in the wild-type group on both days 14 and 21 ( Figure 2a ). This increase in 5-HT-expressing EC cell numbers was statistically significant on day 21 when the wild-type 
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infected group was compared with its noninfected counterpart. However, minimal changes in 5-HT-expressing EC cell numbers were observed in IL-13 − / − mice irrespective of the duration of infection ( Figure 2a ). We have previously established parallels between the number of EC cells and the ability of the mouse to expel the parasite as measured by worm burden. 21 This study also found a similar relationship between worm burden and EC cell numbers ( Figure 1a vs. Figure 2a ). Significantly fewer 5-HT-expressing EC cells were found in IL-13 − / − mice along with increased worm burden. Restoration of IL-13, by treatment with recombinant mouse IL-13 (rmIL-13) for 5 days, in naive IL-13 − / − mice significantly increased both EC cell numbers and 5-HT content in the colon of IL-13 − / − mice ( Figure 3a,b ) . In addition to that, replenishment of IL-13 in naive IL-13 − / − mice resulted in upregulation of TPH1 (tryptophan hydroxylase 1) protein, the rate-limiting enzyme involved in the biosynthesis of 5-HT by EC cells ( Figure 3c ). Upregulation of EC cell number and 5-HT amount was observed in infected IL-13 − / − mice treated with rmIL-13 ( Figure 4a,b ) . Restoration of IL-13 levels improved the ability of IL-13 − / − animals to expel the parasite, as indicated by worm burden (number of worms found was 176 ± 43.2 and 100.5 ± 27.1 in IL-13 − / − mice that received vehicle and rmIL-13, respectively). Interestingly, although there was a significantly increased production of IL-4 in the IL-13 − / − mice compared with wild-type mice after infection, the number of EC cells remained unchanged ( Figure 1b vs. Figure 1a ). These observations provide evidence in favor of a key role of IL-13 in the regulation of EC cell biology and 5-HT production in enteric infection caused by T. muris .
IL-13 upregulates 5-HT concentration in both the cell and media of BON cells
Previously, we have shown that 5-HT-expressing EC cells in the mouse colon express IL-13R 1. 22 In this study we observed that IL-13 plays an important role in promoting EC hyperplasia and 5-HT production. In examining the molecular mechanisms associated with IL-13 and EC cell function, we began by describing the expression of IL-13R 1 in BON cells ( Recent studies have identified two isoforms of the TPH enzyme: TPH1, which is present in mainly peripheral organs such as the EC cells in gut, and TPH2, which is associated with the nervous system and is present predominantly in the brain stem. 31, 32 In this study we have detected TPH1 in BON cells and examined its expression over 24 h. TPH1 expression in BON cells has been 
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previously described. 33 TPH1 expression in BON cells increases significantly, almost two fold, after 4 h of treatment with rhIL-13, but returns to levels similar to the control at 24 h ( Figure 8a ). However, TPH1 protein levels, as determined by western blot, were increased after 24 h ( Figure 8b ).
IL-13 induces BON cell hyperplasia
The number of BON cells was quantified using two different methods, both of which were found to be significantly elevated in IL-13-treated samples ( Figure 9 ). Trypan blue was used to select for live cells; typically, 97 -99 % of the cells were found to be viable. Cells were counted manually using a hemocytometer ( Figure 9a ). Treatment of BON cells with rhIL-13 (10 ng ml − 1 ) for 24 h resulted in significantly increased fluorescence, as determined by the cell viability reagent alamarBlue, which is a function of increased cell number ( Figure 9b ). The ability of IL-13 to induce BON cell hyperplasia was further confirmed utilizing 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay, a cell proliferation assay ( Figure 9c ).
DISCUSSION
5-HT is a well-known neurotransmitter of the central nervous system, and traditionally it is known to influence a range of behavioral, physiological, and cognitive functions. However, the vast majority of 5-HT in the body ( ~ 98 % ) is found outside of the central nervous system and is generated mainly by the EC cells situated within the epithelial layer of the gut mucosa, which are the best-characterized endocrine cell population in the GI tract. 1, 2 Despite the association of alteration in 5-HT response and a variety of GI disorders such as IBS, inflammatory bowel disease, celiac disease, and colorectal cancer, it is not clear how the changes in 5-HT take place, what role 5-HT has in intestinal 
ARTICLES
pathophysiology, and whether by modulating 5-HT production and signaling is it possible to elicit a therapeutic effect. In this study, by employing in vivo mouse model of enteric infection and in vitro model of human EC cells, we have demonstrated a critical role of IL-13 in the development of EC cell hyperplasia and in the upregulation of 5-HT production.
Interactions among immune system, nervous system, and endocrine system have been suggested by a number of studies, and a key player in these neuroimmunoendocrine networks of both human and rodents is 5-HT. The reduced numbers of EC cells in the colon of mice with targeted disruption of IL-2 (ref. 34 ) and T cell receptor-, 35 and the presence of EC cells in contact with, or very close proximity to, CD3 + lymphocytes 28 strongly suggest the existence of the immunological control on EC cells. It is also shown that interferon-has an inhibitory effect on proliferation of BON cells. 36 Recently, the link between EC cells and the immune system during enteric infection has been examined in several studies. 20 -22,37 Infection with a nematode parasite produces mucosal inflammation and induces changes in intestinal physiology, and thus these models have considerable importance in exploring the pathophysiology of many GI disorders. It has been shown that infection with T. spiralis results in the upregulation of EC cells, and this effect is attenuated in infected T cell receptor knockout mice. 20 Utilizing T. muris mouse model of enteric infection, we have previously shown an important connection between immune and endocrine systems in the gut, where secretory products from CD4 + T cells interact with EC cells or their precursors to enhance 5-HT production in the gut via Th2-based mechanisms. 21 We have also observed that EC cell and 5-HT responses induced by the same enteric infectious agent are influenced by Th1 or Th2 cytokine predominance, suggesting the importance of the immunological profile of the inflammatory response in the regulation of EC cell biology. 22 In addition, it is reported that infection-induced reduction of EC cells numbers in Citrobacter rodenitium is not evident in SCID mice, further indicating an important role of the immune system in mediating EC cell hyperplasia in the gut. 36 In this study we observed that EC cell numbers were significantly increased in T. muris -infected wild-type mice as compared with the control. However, in IL-13 − / − mice there was no significant increase in EC cell numbers after the infection as compared with the noninfected controls and this impairment in the development of EC cell hyperplasia is accompanied with delayed worm expulsion from the intestine. Treatment of naive IL-13 − / − mice with recombinant IL-13 for 5 days significantly increased both EC cell numbers and 5-HT amount in the colon. Administration of rmIL-13, over a 15-day period, in T. muris -infected IL-13 − / − mice was also accompanied by upregulation of EC cell numbers and 5-HT content, as well as facilitation of worm expulsion. These observations suggest that IL-13 plays a prominent role in mediating the upregulation of 5-HT-expressing EC cell numbers and in the production of 5-HT in infection-induced inflammatory condition and this may contribute to host defense in this infection. 
We have previously reported the expression of IL-13 R but not IL-4 receptor in mouse EC cells in the colon. 22 The findings from in vivo investigations that recombinant IL-13 can influence the EC cell numbers in the colon and 5-HT content has led us to hypothesize that IL-13 can regulate 5-HT production by acting directly on EC cells and influencing TPH1 (rate-limiting enzyme of 5-HT synthesis) expression and function of EC cells.
In this study we have identified and characterized the expression of IL-13 R in BON cells, a cell culture model of human EC cells. Incubation of BON cells with IL-13 for 24 h results in both increased extracellular and intracellular 5-HT content. TPH1 was originally thought to be regulated at the transcriptional level as slightly elevated nocturnal 5-HT content and TPH1 mRNA levels were found in the rat pineal gland. 38, 39 Recent studies have 
suggested that posttranslational regulation of TPH1 may be more important than transcription activation. 39 In BON cells, activation of the phasphatidylinositol-3-kinase / protein kinase B (Akt) signaling pathway results in the loss of TPH1 protein, potentially by posttranslational degradation, with concomitant decrease 5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT)-based cell growth determination kit (Sigma) was utilized and optical density (OD) was measured at 540 nm. Each bar represents mean ± s.e.m. of eight biological triplicates (wells). * P < 0.05; * * P < 0.01; * * * P < 0.001.
in 5-HT synthesis. 40 TPH1 is a target of cAMP-dependent protein kinase, resulting in phosphorylation of serine 58 in vitro , and an increase in the catalytic activity of TPH1. 41, 42 Our study found that TPH1 mRNA expression increased after 4 h of IL-13 treatment and this was associated with upregulation of protein levels of TPH1 at 24 h. These observations provide evidence that IL-13 regulates 5-HT production from EC cells by enhancing TPH1 activity.
A study by Ishizuka et al. 43 showed that 5-HT itself can act as a mitogen on BON cells; however, significant differences were only observed after 4 days. In our study we observed that IL-13 treatment increases the number of BON cells in culture after 24 h, which is associated with an increase in 5-HT content within the media. Potentially, 5-HT and IL-13 may act synergistically to increase the number of BON cells in culture as well as a similar mechanism may be responsible for EC cell hyperplasia during a Th2-mediated response to enteric infection.
In conclusion, we have shown that IL-13 plays an important role in the development of EC cell hyperplasia in enteric infection-induced model of gut inflammation. IL-13 secreted from Th2 cells or natural killer T cells 44 may control EC cell biology acting via IL-13 receptor on EC cell. In addition, this study also suggests that 5-HT production and worm expulsion share a common immunologic basis and may be causally linked. Using BON cells, a model for human EC cells, we have shown that IL-13 can influence 5-HT synthesis through modulation of TPH1 activity at both the level of mRNA and protein expression. These observations clearly demonstrate a vital role of IL-13 in EC cell biology and 5-HT production and provide important information on immunoendocrine axis in the gut. Furthermore, by manipulating the host immune response, we are able to modulate the accompanying EC cell response and 5-HT production, and this may have clinical relevance. Alterations in EC cell numbers and 5-HT production occur in a variety of clinical settings associated with inflammation and immune activation such as IBS and inflammatory bowel disease. An understanding of the underlying immunological mechanisms of altered EC cell biology, coupled with the ability to modulate EC cell function by immune mediator as depicted in this study, may ultimately yield new therapeutic strategies in these conditions. METHODS Animals . IL-13 − / − mice on a BALB / c background (kindly provided by A. McKenzie, MRC Lab, Cambridge, UK 45 ) were bred at McMaster University. Male IL-13 − / − mice and their age-matched (average age 8 -11 weeks) wild-type counterparts were used for the purposes of these experiments. The guidelines implemented by the McMaster University Animal Care Committee, Canadian Council on the Use of Laboratory Animals, and the Home Office Scientific Procedures Act (1986) were strictly followed. All mice were kept in sterilized, filter-topped cages, and fed autoclaved food in the animal facilities.
BON cell culture . BON cells (obtained from Dr L. Mayer, Mount
Sinai School of Medicine, New York, NY) were maintained in Dulbecco ' s modified Eagle ' s medium / F-12 media, containing 10 % non-heat-treated fetal calf serum at 37 ° C in 5 % CO 2 . Media were changed every 72 h, and all experiments were performed on BON cells from passages 6 -14 in this study.
Experimental design for T. muris infection . The techniques used for T. muris maintenance and infection were described previously. 46, 47 Mice were infected with ~ 300 eggs by oral gavage on day 0 and were killed on days 14 and 21, and at these time points tissue samples were collected. In a separate experiment, IL-13 − / − mice were treated with either rmIL-13 (2 g day − 1 ) or vehicle (phosphate-buffered saline (PBS)) for 15 days, starting 1 day before infection with T. muris . The duration of infection in the latter experiments was 14 days, and thereafter the animals were killed and tissue samples were collected. Additionally, in another experiment, naive IL-13 − / − mice were treated with aforementioned rmIL-13 dose or PBS and killed on day 5. RNA isolation and reverse transcriptase reaction . RNA from ~ 1 × 10 6 BON cells that were treated with or without 10 ng ml − 1 rhIL-13 was isolated using Total RNA Purification kit from Norgen Biotek (Thorold, Ontario, Canada). Purified RNA was quantified and the integrity of RNA was determined using the Experion bio analyzer with a standard sensitivity RNA chip (Bio-Rad Laboratories). All RNA samples were found to be of sufficient integrity with minimal RNA degradation (RNA quality indicator (RQI) > 8. 5 ). An aliquot of 3 g of RNA was used for reverse transcription using 0.5 g of oligo (dT) 12 − 18 with the M-MLV Research Transcriptase (Invitrogen, Grand Island, NY) kit. The complementary DNA (cDNA) samples were diluted 1:10, and cDNA pooled samples were diluted in a 10-fold serial dilution to create a standard curve with autoclaved ddH 2 O.
Quantitative Real-time PCR . All real-time PCR reactions were performed using the Bio-Rad CFX 96 PCR system (Bio-Rad Laboratories) and amplification reactions (10 l) were done using 5 l of EvaGreen PCR Master Mix (Bio-Rad Laboratories), 1 l of both the 10 M reverse and forward primers, 2 l of autoclaved ddH 2 O, and 1 l of diluted cDNA.
The optimal annealing temperature of 58 ° C was determined for the TPH1 primers (forward: 5 Ј -TGCCCTTGCTAAGGTCAGCAGGA-3 Ј , reverse: 5 Ј -AGCAAGAGATGGCCCAGACCTCC-3 Ј ). The thermal cycling conditions were as follows: initial denaturation of 30 s at 95 ° C followed by amplification for 40 cycles of 5 s at 95 ° C and 5 s at 58 ° C. Using multiple classical internal control genes we assessed the variability of each gene using a random subset of the cDNA samples and assessed the stability of the reference gene using geNorm ARTICLES ( http://medgen.ugent.be/ ~ jvdesomp/genorm/ ) and as described by Vandesompele et al. 48 The reference gene primers that we utilized were as follows: glyceraldehyde-3-phosphate dehydrogenase (GAPDH), forward: 5 Ј -CCCTCCAAAATCAAGTGGGGCG-3 Ј and reverse: 5 Ј -ATGACGAACATGGGGGCATCAGC-3 Ј ; -Actin, forward: 5 Ј -ATGTGGCCGAGGACTTTGATT-3 Ј and reverse: 5 Ј -AGTGGGGTGGCTTTTAGGATG-3 Ј ; Ubiquitin C (UBC), forward: 5 Ј -ATTTGGGTCGCGGTTCTTG-3 Ј and reverse: 5 Ј -TGCCT TGACATTCTCGATGGT-3 Ј ; 18S rRNA, forward: 5 Ј -TCCACAGGAGGC CTACACGCC-3 Ј and reverse: 5 Ј -TTTCCGCCGCCCATCGATGTT-3 Ј .
We found the 18S rRNA gene to be most stable according to geNorm (average expression stability (M) = 0.401) and the other reference genes to be less stable (M = 0.548 to 0.526), and therefore the 18S rRNA gene was selected for subsequent relative quantification of TPH1 at each time point.
TPH1 western blotting . Colonic tissue samples of IL-13 − / − mice treated with or without rmIL-13 (2 g day − 1 for 5 days) were homogenized in the same manner as samples prepared for determination of tissue cytokine levels. Once again, concentration of the total protein in the solution of homogenized tissue was determined using a DC Protein Assay kit (Bio-Rad).
BON cell lysate was prepared in 6 cm dishes and pre-treated with or without rhIL-13 (10 ng ml − 1 ) for different time periods (1, 4, 6 , and 24 h). After treatment, the cells were washed with ice-cold PBS, and 300 l of lysis buffer (50 m m Tris-HCl (pH 8); 150 m m NaCl; 1 % Triton X-100) containing protease and phosphatase inhibitors (0.5 mmol l − 1 Na 3 VO 4 , 10 mmol l − 1 NaF, 1 mol l − 1 leupeptin, 1 mol l − 1 pepstatin, 1 mol l − 1 okadaic acid, and 0.2 mmol l − 1 phenylmethylsulfonyl fluoride) was added. An aliquot of the cell lysate was used to determine the protein concentration in each sample.
Before loading onto sodium dodecyl sulfate (SDS) -polyacrylamide gel electrophoresis gels, the samples, both tissue and cell, were diluted 1:1 (vol / vol) with 2 × Laemmli sample buffer (62.5 mmol l − 1 Tris-HCl (pH 6.8), 2 % (wt / vol) SDS, 50 mmol l − 1 dithiothreitol, and 0.01 % (wt / vol) bromophenol blue). Aliquots of cell lysates and tissue homogenate (equal amount from each group) containing 20 and 30 g of protein, respectively, were then subjected to SDS -polyacrylamide gel electrophoresis and then transferred to polyvinylidene difluoride membranes. The total TPH1 protein level was detected using a specific antibody (1:1,000; Abgent, San Diego, CA), and primary antibody detection was performed using horseradish peroxidase -conjugated appropriate secondary antibody. Signal was visualized using enhanced chemiluminescence, and quantified using the ImageJ program (National Institutes of Health, Bethesda, MD).
Immunohistochemistry . Immunohistochemical studies of 5-HTexpressing EC cells were performed on formalin-fixed, paraffinwax-embedded samples as described previously. 22 Briefly, tissue sections were deparaffinized in CitriSolv (Fisher Scientific, Mississauga, Ontario, Canada), and rehydrated in increasingly less ethanol in PBS. Endogenous peroxide activity was blocked for 30 min (DakoCytomation, Burlington, Ontario, Canada). Antigen retrieval was accomplished using hot 10 m M Citrate Buffer (pH 6.0). Nonspecific binding was reduced using 1 % bovine serum albumin in PBS; sections were then incubated with 5-HT rabbit antibody (Immunostar, Hudson, WI; 1:5,000; 1 h at room temperature). Secondary antibody was then applied for 30 min (Envision, DakoCytomation; horseradish peroxidise -coupled antirabbit secondary reagent; DakoCytomation). Sections were developed with 3,3 Ј -diaminobenzidine and counterstained with Meyer ' s hematoxylin. Quantification of 5-HT-positive EC cells was conducted by a blinded observer and expressed as number of positive cells per 10 glands.
Immunocytofluorescence . BON cells were grown in a 12-well dish in the presence of a glass circular cover slip. Media were removed and cell washed with PBS. Fixation with 2 % paraformaldehyde in PBS was performed first at room temperature for 10 min. Cells were permeabilized with 0.1 % Triton X-100 and 0.1 % Saponin in PBS at room temperature for 15 min. A second fixation step was then performed with 4 % paraformaldehyde in PBS. Cells were blocked with 3 % bovine serum albumin in PBS for 1 h at room temperature. Primary antibody at indicated dilution was applied to the cells in PBS containing 3 % bovine serum albumin, 0.1 % Triton X-100, and 0.1 % saponin overnight, shaking at 4 ° C. The cells were washed 3 times with PBS containing 0.1 % Triton X-100, and 0.1 % saponin. Secondary antibody was applied at indicated dilution to cells in PBS containing 3 % bovine serum albumin, 0.1 % Triton X-100, and 0.1 % saponin, shaking at room temperature for 1 h. Cells were then washed 3 times with PBS containing 0.1 % Triton X-100, and 0.1 % saponin. Cover slips were mounted on to slides using ProLong Gold with 4 Ј , 6-diamidino-2-phenylindole (Invitrogen).
BON cell proliferation assay . Commercially available MTT based cell growth determination kit (Sigma) was utilized to measure BON cell proliferation. Approximately 1 × 10 4 cells in 200 l of aforementioned medium were seeded in triplicates into 96-well culture plates and incubated for 48 h to allow cell adhesion. Thereafter, 200 l of serum-free medium either with or without 10 ng ml − 1 of rhIL-13 was added to the wells containing cells and incubated at 37 ° C, 5 % CO 2 for 24 h. At the end of incubation, 20 l of MTT was added to all wells and incubated for an hour and a half, following which the medium was removed and the plate was dried at 37 ° C for 1 h. After 1 h, 200 l of 0.04 M HCl in isopropanol was added to each well and mixed thoroughly. Optical density was measured at 540 nm using a luminometer (EL 808; Bio-Tek Instruments, Winooski, VT).
Statistical analysis . Comparison of the two groups was accomplished using Student ' s t -test. Comparison of three or more groups was accomplished first using a one-way analysis of variance followed by the NewmanKeuls multiple comparison test unless otherwise indicated. The P -values are designated as follows: * 0.05, * * 0.01, * * * 0.001, and * * * * 0.0001. All statistical analyses were performed using GraphPad Prism 5 (La Jolla, CA).
